Healthcare Practices
The Preeclampsia Foundation announced today that the Centers for Disease Control and Prevention (CDC) awarded new funding for its MoMMA’s Voices program, a national coalition of patient advocacy organizations and individuals with "lived experience" –...
The U.S. Preventive Services Task Force (USPSTF) released today a final recommendation statement on screening for hypertensive disorders of pregnancy. The Task Force recommends that all pregnant people have their blood pressure measured throughout pr...
Abt Associates, together with subcontractors HealthBegins and the MoMMA’s Voices program of the Preeclampsia Foundation, will provide technical assistance and evaluation support to 36 HRSA-supported health centers who are implementing innovative appr...
Recommendations for high-risk expecting parents and health care providers to promote the prevention of preeclampsia, a leading cause of pregnancy-related death in the United States.
Education Manager Maggie Barker recaps the 2022 Alliance for Innovation in Maternal Health Conference.
The Preeclampsia Foundation announced that its Cuff Kit™ program is a Phase 1 winner of the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) Hypertension Innovator Award Competition.
Preeclampsia puts women at increased risk for heart disease as well as stroke and high blood pressure later in life. Large population studies have demonstrated that two of three preeclampsia survivors will die of heart disease. That’s news to m...
The Preeclampsia Foundation, a patient advocacy organization for those affected by high blood pressure in pregnancy, is partnering with Shaconna Haley to present a special webinar on Wed. Dec. 1, 2021 at 1 pm for doulas on their role to support and e...
On Jan. 25-26, the Society for Maternal-Fetal Medicine (SMFM) and the Preeclampsia Foundation will bring together leading national and international clinicians and researchers for an in-depth look at how to better predict, prevent, and manage preecla...
The Preeclampsia Foundation is urgently calling for the development of biomarker tests for simple, rapid, and accurate diagnosis and prediction of preeclampsia, a life-threatening hypertensive disorder of pregnancy. This call-to-action statement reco...
The Preeclampsia Foundation is responding to the needs of pregnant and postpartum women, during COVID-19, with the introduction of The Cuff Kit™.
This article was originally written in 2013, but is still especially relevant today on National Nurses Day during the COVID-19 pandemic. Thank you to all the many nurses and midwives in our community who do what is best for their patients! In 2013,...